EXDL3 Inhibitors
Chemical inhibitors of EXDL3 can function through various mechanisms, primarily by disrupting the cellular architecture and dynamics that are essential for EXDL3's activity. Paclitaxel acts by stabilizing microtubules, which are crucial for cell cycle progression and other cellular processes. This stabilization hampers the dynamic behavior required for these functions, thereby inhibiting EXDL3's role within these processes. Similarly, Colchicine and Vincristine target tubulin, the building block of microtubules, preventing their polymerization and thus, disrupting the cellular framework necessary for EXDL3 to function. Nocodazole also inhibits microtubule polymerization, further emphasizing the strategy of targeting the microtubular infrastructure to inhibit EXDL3's involvement in microtubule-dependent cellular processes.
In parallel, the actin cytoskeleton provides another avenue for inhibiting EXDL3. Cytochalasin D and Latrunculin A interfere with actin filament polymerization, while Swinholide A severs actin filaments and Jasplakinolide stabilizes them, preventing the dynamic remodeling that is essential for many cellular functions. These disruptions are likely to inhibit EXDL3 function by impairing the cellular processes that depend on actin dynamics. Additionally, Blebbistatin and ML-7 inhibit myosin II and myosin light chain kinase (MLCK), respectively, both of which are key players in cellular contraction and motility. By inhibiting these molecular motors, the chemicals can impair the cellular mechanics with which EXDL3 is associated. Y-27632, as a ROCK inhibitor, and CK-636, as an Arp2/3 complex inhibitor, also target the regulation of the cytoskeleton, highlighting the role of cytoskeletal dynamics in modulating EXDL3 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and as a result, can inhibit the dynamics required for cell cycle progression and cellular processes. Since EXDL3 is involved in cellular mechanisms, the stabilization of microtubules by Paclitaxel could inhibit EXDL3's functions related to these processes. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, inhibiting microtubule polymerization, which can disrupt EXDL3's role in cellular processes that depend on the microtubule network. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin filament polymerization. Since actin dynamics are crucial for many cellular processes, this disruption can inhibit EXDL3's role in any cellular functions that require the actin cytoskeleton. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers, preventing their polymerization. This impairs actin cytoskeleton functions and could inhibit EXDL3's involvement in cellular processes that are dependent on actin dynamics. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin inhibits myosin II ATPase activity. As myosin II is an important motor protein for cellular mechanics, its inhibition can affect cellular functions, potentially inhibiting EXDL3 if it is involved in processes reliant on myosin II activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, affecting cytoskeleton dynamics and cell motility. Inhibition of ROCK can disrupt cellular processes, potentially inhibiting EXDL3 if its function is related to pathways involving ROCK signaling. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK), which is involved in the regulation of cellular contraction and morphology. Inhibition of MLCK could inhibit EXDL3 by affecting cellular processes that rely on the contractile apparatus regulated by MLCK. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule networks by inhibiting microtubule polymerization. This disruption can inhibit EXDL3's function in cellular processes that are microtubule-dependent. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Swinholide A severs actin filaments and prevents their reannealing. This action could inhibit EXDL3 by disrupting cellular processes that depend on the actin cytoskeleton structure and functions. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can inhibit cellular processes requiring dynamic actin remodeling, potentially inhibiting EXDL3's functions associated with such processes. | ||||||